DRAP Authorizes Clinical Trial for COVID-19 Vaccine
According to the document signed by DRAP Clinical Studies Committee Secretary Shafqat Hussain Danish, the trial will be held at Indus Hospital, Karachi.
It has been confirmed that Drug Regulatory Authority Pakistan (DRAP) has authorized a clinical trial for COVID-19 Vaccine in Karachi, Pakistan. According to the document signed by DRAP Clinical Studies Committee Secretary Shafqat Hussain Danish, the trial will be held at Indus Hospital.
These tests will be carried out by the International Centre for Chemical and Biological Sciences in Karachi, along with a Chinese company which is already conducting tests in China.
The trial will be concluded in 56 days – during this time period three inactivated virus injections will be administered to the 200 volunteers that have registered. The volunteers are both male and female from different ethnic backgrounds.
Monthly reports will be submitted by the National Data Safety Monitoring Committee regarding the safety of the patients.
One of the members of the Scientific Task Force on COVID-19, constituted by Minister Fawad Chaudhry, gave details about the trials, “The trial will commence from next week which will be participated by 200 volunteers, all over 18 years of age. We have selected volunteers from various ethnic groups to analyse their results. I believe Karachi is the most appropriate city as people from all backgrounds are settled there.”
The member added that the virus will be injected on day zero, day 28 and day 56 of the trials to test the antibodies. Rs 50,000 will be paid to each volunteer for their service, and after the completion of the trial, they will move on to other cities.
When talking about the side effects, the member stated, “These [mild fever, tiredness, headache or allergy] are mild symptoms and people should know that even the committee members are willing to volunteer themselves for the trial. We are taking part in global efforts against COVID-19. Moreover, as we are passing through the ‘fifth generation warfare’ phase, the trial will build a positive image of Pakistan.”
We hope that DRAP’s decision to authorize a clinical trial for COVID-19 vaccine leads to good news and for the betterment of people.
To read our review of the Playstation 5, click here.
About Us:
Runway Pakistan is a complete solution provider for all your marketing communications related requirements. The ultimate hub of infotainment – Runway composes of all the key offerings – Monthly Print Magazine, Digital Magazine, Media Production, Creative Agency, PR Agency and Marketing Consultancy that a brand needs to be seen, heard and known!
Like and follow our Facebook page:
